ACM
AGN

Arrow Capital Management’s Allergan plc AGN Stock Holding History

Arrow Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$461K Sell
2,000
-13,000
-87% -$3.18M 0.59% 18
2016
Q2 		$3.47M Buy
15,000
+4,298
+40% +$991K 5.65% 7
2016
Q1 		$2.87M Sell
10,702
-22,999
-68% -$6.58M 3.18% 17
2015
Q4 		$10.5M Buy
33,701
+31,901
+1,772% +$9.5M 9.23% 5
2015
Q3 		$490K Buy
+1,800
New +$553K 0.41% 16

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Arrow Capital Management's AGN Position: Q3 2016 in Review

Arrow Capital Management reduced its Allergan plc (AGN) stake by 87% in Q3 2016, selling an estimated $3.18M and leaving 2,000 shares worth $461K. The position accounts for 0.59% of the portfolio, ranked #18.

Arrow Capital Management first reported a position in AGN in Q3 2015 and has held it in 5 quarters since. The position peaked at $10.5M in Q4 2015. 1,105 funds tracked by Wall St. Rank hold AGN as of Q3 2016.

  • Arrow Capital Management held 2,000 shares of Allergan plc worth $461K as of Q3 2016.
  • Arrow Capital Management sold 13,000 Allergan plc shares in Q3 2016, an estimated $3.18M.
  • Allergan plc made up 0.59% of Arrow Capital Management's portfolio in Q3 2016, its #18 holding.
  • Arrow Capital Management first reported a position in Allergan plc in Q3 2015 and has held it in 5 quarters since.
  • Arrow Capital Management's Allergan plc position peaked at $10.5M in Q4 2015.
  • 1,105 funds tracked by Wall St. Rank held Allergan plc as of Q3 2016.

Based on Arrow Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.